Equities analysts expect Docusign Inc (NASDAQ:DOCU) to post sales of $160.07 million for the current quarter, Zacks reports. Four analysts have provided estimates for Docusign’s earnings. The lowest sales estimate is $158.20 million and the highest is $164.07 million. The business is expected to report its next earnings results on Thursday, September 6th.
According to Zacks, analysts expect that Docusign will report full-year sales of $658.56 million for the current financial year, with estimates ranging from $655.00 million to $670.03 million. For the next year, analysts anticipate that the business will report sales of $794.31 million per share, with estimates ranging from $779.30 million to $809.32 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Docusign.
Docusign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, June 7th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.14. The company had revenue of $155.81 million for the quarter, compared to analyst estimates of $145.87 million. The firm’s quarterly revenue was up 37.3% on a year-over-year basis.
In related news, Director Keith J. Krach sold 165,026 shares of Docusign stock in a transaction dated Tuesday, May 1st. The stock was sold at an average price of $29.00, for a total value of $4,785,754.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Ignition Gp Ii, Llc sold 784,843 shares of Docusign stock in a transaction dated Tuesday, May 1st. The stock was sold at an average price of $29.00, for a total value of $22,760,447.00. The disclosure for this sale can be found here.
DOCU traded up $0.42 during midday trading on Friday, hitting $63.95. 3,584,226 shares of the company were exchanged, compared to its average volume of 1,608,219. Docusign has a 1-year low of $37.00 and a 1-year high of $65.82.
Docusign Company Profile
There is no company description available for Docusign Inc
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.